Skba Capital Management LLC grew its stake in Cardinal Health, Inc. (NYSE:CAH) by 10.3% in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 102,440 shares of the company’s stock after purchasing an additional 9,600 shares during the period. Skba Capital Management LLC’s holdings in Cardinal Health were worth $6,855,000 at the end of the most recent reporting period.
Several other large investors also recently bought and sold shares of CAH. Fox Run Management L.L.C. bought a new stake in shares of Cardinal Health in the 2nd quarter valued at approximately $234,000. Alpha Windward LLC lifted its stake in shares of Cardinal Health by 0.7% during the 2nd quarter. Alpha Windward LLC now owns 2,299 shares of the company’s stock worth $179,000 after acquiring an additional 17 shares during the last quarter. Manning & Napier Advisors LLC bought a new stake in shares of Cardinal Health during the 2nd quarter worth approximately $5,366,000. Osborn Williams & Donohoe LLC lifted its stake in shares of Cardinal Health by 6.6% during the 2nd quarter. Osborn Williams & Donohoe LLC now owns 24,882 shares of the company’s stock worth $1,939,000 after acquiring an additional 1,551 shares during the last quarter. Finally, Farmers & Merchants Investments Inc. lifted its stake in shares of Cardinal Health by 22.2% during the 2nd quarter. Farmers & Merchants Investments Inc. now owns 49,641 shares of the company’s stock worth $3,868,000 after acquiring an additional 9,002 shares during the last quarter. 88.50% of the stock is owned by institutional investors and hedge funds.
ILLEGAL ACTIVITY WARNING: “Skba Capital Management LLC Has $6.86 Million Stake in Cardinal Health, Inc. (CAH)” was originally reported by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are accessing this piece on another publication, it was illegally copied and republished in violation of U.S. & international trademark and copyright laws. The original version of this piece can be viewed at https://www.dispatchtribunal.com/2017/11/20/skba-capital-management-llc-has-6-86-million-stake-in-cardinal-health-inc-cah.html.
A number of brokerages recently issued reports on CAH. UBS AG reissued a “neutral” rating and set a $76.00 price target (down from $79.00) on shares of Cardinal Health in a research note on Thursday, August 3rd. BidaskClub lowered Cardinal Health from a “buy” rating to a “hold” rating in a research note on Monday, July 24th. Zacks Investment Research lowered Cardinal Health from a “hold” rating to a “sell” rating in a research note on Monday, August 7th. Cowen and Company restated a “market perform” rating and set a $77.00 price objective (down from $82.00) on shares of Cardinal Health in a report on Thursday, August 3rd. Finally, Needham & Company LLC restated a “hold” rating on shares of Cardinal Health in a report on Thursday, October 12th. One research analyst has rated the stock with a sell rating, twelve have assigned a hold rating and five have assigned a buy rating to the stock. The company currently has a consensus rating of “Hold” and a consensus price target of $74.81.
Shares of Cardinal Health, Inc. (NYSE:CAH) traded up $0.09 during trading hours on Monday, hitting $57.51. The stock had a trading volume of 3,800,400 shares, compared to its average volume of 2,370,989. Cardinal Health, Inc. has a twelve month low of $55.69 and a twelve month high of $84.88. The stock has a market cap of $18,130.00, a P/E ratio of 10.91, a PEG ratio of 1.66 and a beta of 0.88. The company has a debt-to-equity ratio of 1.35, a current ratio of 1.06 and a quick ratio of 0.52.
Cardinal Health (NYSE:CAH) last posted its quarterly earnings data on Monday, November 6th. The company reported $1.09 earnings per share for the quarter, topping the Zacks’ consensus estimate of $1.00 by $0.09. The firm had revenue of $32.64 billion during the quarter, compared to analysts’ expectations of $33.48 billion. Cardinal Health had a return on equity of 25.24% and a net margin of 0.84%. The business’s quarterly revenue was up 1.9% on a year-over-year basis. During the same quarter last year, the firm earned $1.24 EPS. sell-side analysts forecast that Cardinal Health, Inc. will post 4.97 EPS for the current fiscal year.
The firm also recently disclosed a quarterly dividend, which will be paid on Monday, January 15th. Stockholders of record on Tuesday, January 2nd will be given a $0.4624 dividend. The ex-dividend date is Friday, December 29th. This represents a $1.85 dividend on an annualized basis and a dividend yield of 3.22%. Cardinal Health’s payout ratio is 53.94%.
Cardinal Health Profile
Cardinal Health, Inc is a healthcare services and products company. The Company operates through two segments: Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, over-the-counter healthcare and consumer products. This segment also operates nuclear pharmacies and cyclotron facilities; provides pharmacy management services to hospitals, as well as medication therapy management and patient outcomes services to hospitals, other healthcare providers and payers, and provides services to healthcare companies.
Receive News & Ratings for Cardinal Health Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health Inc. and related companies with MarketBeat.com's FREE daily email newsletter.